Carbohydrate antigen 19-9 elevation in anatomically resectable, early stage pancreatic cancer is independently associated with decreased overall survival and an indication for … JR Bergquist, CA Puig, CR Shubert, RT Groeschl, EB Habermann, ... Journal of the American College of Surgeons 223 (1), 52-65, 2016 | 160 | 2016 |
Neoadjuvant cabozantinib and nivolumab converts locally advanced HCC into resectable disease with enhanced antitumor immunity. WJ Ho, Q Zhu, J Durham, A Popovic, S Xavier, J Leatherman, A Mohan, ... Nature cancer 2 (9), 891-903, 2021 | 150 | 2021 |
Clinical risk score to predict pancreatic fistula after pancreatoduodenectomy: independent external validation for open and laparoscopic approaches CR Shubert, AE Wagie, MB Farnell, DM Nagorney, FG Que, ... Journal of the American College of Surgeons 221 (3), 689-698, 2015 | 123 | 2015 |
A NSQIP review of major morbidity and mortality of synchronous liver resection for colorectal metastasis stratified by extent of liver resection and type of colorectal resection CR Shubert, EB Habermann, JR Bergquist, CA Thiels, KM Thomsen, ... Journal of Gastrointestinal Surgery 19 (11), 1982-1994, 2015 | 93 | 2015 |
Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: an … CR Shubert, JR Bergquist, RT Groeschl, EB Habermann, PM Wilson, ... Surgery 160 (4), 1080-1096, 2016 | 88 | 2016 |
Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity WJ Ho, Q Zhu, J Durham, A Popovic, S Xavier, J Leatherman, A Mohan, ... Nature Cancer 2 (9), 891-903, 2021 | 67 | 2021 |
Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience Z Jin, ML Hartgers, CT Sanhueza, CR Shubert, SR Alberts, MJ Truty, ... European Journal of Surgical Oncology 44 (5), 677-683, 2018 | 56 | 2018 |
Precision medicine in pancreatic cancer: patient-derived organoid pharmacotyping is a predictive biomarker of clinical treatment response TT Seppälä, JW Zimmerman, R Suri, H Zlomke, GD Ivey, A Szabolcs, ... Clinical Cancer Research 28 (15), 3296-3307, 2022 | 53 | 2022 |
Laparoscopic pancreatoduodenectomy does not completely mitigate increased perioperative risks in elderly patients MC Tee, KP Croome, CR Shubert, MB Farnell, MJ Truty, FG Que, ... HPB 17 (10), 909-918, 2015 | 47 | 2015 |
Mixed hepatocellular and cholangiocarcinoma: a rare tumor with a mix of parent phenotypic characteristics JR Bergquist, RT Groeschl, T Ivanics, CR Shubert, EB Habermann, ... Hpb 18 (11), 886-892, 2016 | 43 | 2016 |
Defining perioperative risk after hepatectomy based on diagnosis and extent of resection CR Shubert, EB Habermann, MJ Truty, KM Thomsen, ML Kendrick, ... Journal of Gastrointestinal Surgery 18 (11), 1917-1928, 2014 | 41 | 2014 |
Current surgical management strategies for colorectal cancer liver metastases GD Ivey, FM Johnston, NS Azad, ES Christenson, KJ Lafaro, CR Shubert Cancers 14 (4), 1063, 2022 | 28 | 2022 |
Benefit of postresection adjuvant chemotherapy for stage III colon cancer in octogenarians: analysis of the National Cancer Database JR Bergquist, CA Thiels, BA Spindler, CR Shubert, AV Hayman, ... Diseases of the Colon & Rectum 59 (12), 1142-1149, 2016 | 28 | 2016 |
Isolated congenital agenesis of the gallbladder and cystic duct: report of a case GR Joliat, CR Shubert, DR Farley Journal of surgical education 70 (1), 117-120, 2013 | 28 | 2013 |
Identification of risk categories for in pancreaticoduodenectomy based on diagnosis CR Shubert, ML Kendrick, KM Thomsen, MB Farnell, EB Habermann HPB 17 (5), 428-437, 2015 | 27 | 2015 |
Risk by indication for pancreaticoduodenectomy in patients 80 years and older: a study from the American College of Surgeons National Surgical Quality Improvement Program JR Bergquist, CR Shubert, DS Ubl, CA Thiels, ML Kendrick, MJ Truty, ... HPB 18 (11), 900-907, 2016 | 25 | 2016 |
Preoperative anemia is associated with increased use of hospital resources in patients undergoing elective hepatectomy MC Tee, CR Shubert, DS Ubl, EB Habermann, DM Nagorney, FG Que Surgery 158 (4), 1027-1038, 2015 | 23 | 2015 |
Type of resection (Whipple vs. distal) does not affect the national failure to provide post-resection adjuvant chemotherapy in localized pancreatic cancer JR Bergquist, T Ivanics, CR Shubert, EB Habermann, RL Smoot, ... Annals of surgical oncology 24, 1731-1738, 2017 | 21 | 2017 |
Is chemotherapy or radiation therapy in addition to surgery beneficial for locally advanced rectal cancer in the elderly? A National Cancer Data Base (NCDB) Study JR Bergquist, CA Thiels, CR Shubert, EB Habermann, AV Hayman, ... World journal of surgery 40, 447-455, 2016 | 19 | 2016 |
Implementation of prospective, surgeon-driven, risk-based pathway for pancreatoduodenectomy results in improved clinical outcomes and first year cost savings of $1 million CR Shubert, ML Kendrick, EB Habermann, AE Glasgow, BJ Borah, ... Surgery 163 (3), 495-502, 2018 | 18 | 2018 |